Morphic Holding Inc
(STU:31Y)
€
51
0 (0%)
Market Cap: 2.60 Bil
Enterprise Value: 2.03 Bil
PE Ratio: 0
PB Ratio: 4.62
GF Score: 42/100 Morphic Holding Inc at Canaccord Genuity Growth Conference Transcript
Aug 10, 2023 / 03:30PM GMT
Release Date Price:
€48.4
(-6.92%)
Edward Nash
Canaccord Genuity Group Inc. - Analyst
One for joining us, my name is Edward Nash. I am a senior analyst on the biotech team here at Canaccord Genuity. And I'm joined by my colleague, [Shin Leon], who works in the team with me. We have the pleasure of having with us today the management team of Morphic Therapeutic. With us is the CEO, Praveen Tipirneni; and the Senior Vice President of IR and Corporate Communications, Chris Erdman. Appreciate you both joining us today.
Praveen Tipirneni
Morphic Holding, Inc. - CEO
Thanks you for inviting us, and you guys are quite bold having this in August. Get quite a turnout for it.
Edward Nash
Canaccord Genuity Group Inc. - Analyst
I know, right. A lot of headwinds.
Praveen Tipirneni
Morphic Holding, Inc. - CEO
Yeah.
Edward Nash
Canaccord Genuity Group Inc. - Analyst
So I want to start the conversation. Just to get your audience a little bit of background on the company
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot